Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Goodwill & Intangibles (2012 - 2026)

Precigen (PGEN) posted quarterly Goodwill & Intangibles of $18.1 million for Q1 2026, down 22.25% year-over-year from $23.3 million in Q1 2025, and down 1.73% quarter-over-quarter from $18.4 million in Q4 2025.

Analysis

Precigen (PGEN) Goodwill & Intangibles (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Goodwill & Intangibles for 15 consecutive years, with $18.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Goodwill & Intangibles fell 22.25% year-over-year to $18.1 million; the TTM figure through Mar 2026 stood at $18.1 million (down 22.25% YoY), while the FY2025 annual figure was $18.4 million, down 21.95% from the prior year.
  • Goodwill & Intangibles slipped to $18.1 million in Q1 2026 per PGEN's latest filing, from $18.4 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $105.0 million in Q1 2022 and bottomed at $18.1 million in Q1 2026.
  • Historically, Goodwill & Intangibles has averaged $52.9 million across 5 years, with a median of $65.3 million in 2024.
  • Annual changes were most pronounced in 2023 — Goodwill & Intangibles fell 2.29% — and 2024, when it sank 64.95%.
  • Precigen's Goodwill & Intangibles stood at $81.4 million in 2022, then dropped by 17.28% to $67.3 million in 2023, then tumbled by 64.95% to $23.6 million in 2024, then slipped by 21.95% to $18.4 million in 2025, then slipped by 1.73% to $18.1 million in 2026.
  • Business Quant data shows PGEN's Goodwill & Intangibles at $18.1 million in Q1 2026, $18.4 million in Q4 2025, and $18.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.78 Mn
Mar 31, 2026 18.10 Mn
Dec 31, 2025 18.41 Mn
Sep 30, 2025 18.73 Mn
Jun 30, 2025 19.05 Mn
Mar 31, 2025 23.28 Mn
Dec 31, 2024 23.59 Mn
Sep 30, 2024 29.69 Mn
Jun 30, 2024 30.01 Mn
Mar 31, 2024 65.27 Mn
Dec 31, 2023 67.31 Mn
Sep 30, 2023 77.32 Mn
Jun 30, 2023 79.62 Mn
Mar 31, 2023 80.81 Mn
Dec 31, 2022 81.38 Mn
Sep 30, 2022 79.13 Mn
Jun 30, 2022 82.80 Mn
Mar 31, 2022 105.04 Mn
Dec 31, 2021 89.85 Mn
Sep 30, 2021 111.12 Mn